Literature DB >> 35066780

CircCBFB is a mediator of hepatocellular carcinoma cell autophagy and proliferation through miR-424-5p/ATG14 axis.

Zidan Zhao1, Junjian He1, Chao Feng2.   

Abstract

This study aims to investigate the role of circCBFB in hepatocellular carcinoma (HCC) cell proliferation and autophagy. qRT-PCR and Western blotting analyses quantified the expression levels of circCBFB, miR-424-5p, and ATG14 in HCC tissues and/or HCC cell lines. After transfection with pcDNA3.1-CircCBFB, sh-CircCBFB, miR-424-5p mimic, miR-424-5p inhibitor, pcDNA3.1-ATG14, sh-ATG14, sh-CircCBFB + miR-424-5p inhibitor, pcDNA3.1-CircCBFB + miR-424-5p mimic, sh-CircCBFB + pcDNA3.1-ATG14, or pcDNA3.1-CircCBFB + sh-ATG14, the proliferation, cell cycle, and apoptosis of Huh-7 and HCCLM3 cells were detected, respectively, through MTT assay and flow cytometry. Western blotting measured the expression levels of ATG14 and autophagy-related proteins (LC3-ΙΙ/LC3-Ι, Beclin1, and p62). The interactions among circCBFB, miR-424-5p, and ATG14 were identified through RNA fluorescence in situ hybridization and RNA immunoprecipitation. In HCC tissues, circCBFB and ATG14 were highly expressed, and miR-424-5p expression was downregulated. Transfection of pcDNA3.1-CircCBFB, miR-424-5p inhibitor, or pcDNA3.1-ATG14 into HCC cells facilitated HCC cell proliferation and autophagy, while suppressing cell apoptosis, evidenced by elevated cell viability, increased protein levels of autophagosome markers (LC3-ΙΙ/LC3-Ι and Beclin1), repressed apoptosis rate, and suppressed protein level of autophagy receptor p62. miR-424-5p was a target gene of circCBFB, and miR-424-5p negatively mediated ATG14. CircCBFB inhibits miR-424-5p and upregulates ATG14, thus promoting HCC cell proliferation and autophagy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ATG14; Autophagy; CircCBFB, miR-424-5p; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2022        PMID: 35066780     DOI: 10.1007/s12026-021-09255-8

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  33 in total

1.  Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.

Authors:  Shanshan Wang; Shichang Cui; Wenming Zhao; Zhiling Qian; Hui Liu; Yuhan Chen; Fudong Lv; Hui-Guo Ding
Journal:  Cancer Biomark       Date:  2018       Impact factor: 4.388

2.  A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women.

Authors:  Wanshui Yang; Jing Sui; Yanan Ma; Tracey G Simon; Dawn Chong; Jeffrey A Meyerhardt; Walter C Willett; Edward L Giovannucci; Andrew T Chan; Xuehong Zhang
Journal:  Int J Cancer       Date:  2019-06-06       Impact factor: 7.396

3.  USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.

Authors:  Sunbin Ling; Qiaonan Shan; Qifan Zhan; Qianwei Ye; Peng Liu; Shengjun Xu; Xin He; Jian Ma; Jiajia Xiang; Guangjiang Jiang; Xue Wen; Zijie Feng; Yuan Wu; Tingting Feng; Li Xu; Kangchen Chen; Xuanyu Zhang; Rongli Wei; Chenzhi Zhang; Beini Cen; Haiyang Xie; Penghong Song; Jimin Liu; Shusen Zheng; Xiao Xu
Journal:  Gut       Date:  2019-11-27       Impact factor: 23.059

Review 4.  Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma.

Authors:  Juan Zhou; Xinxin Zhang; Huifang Tang; Jia Yu; Xuyu Zu; Zhizhong Xie; Xiaoyan Yang; Juan Hu; Fang Tan; Qing Li; Xiaoyong Lei
Journal:  Clin Chim Acta       Date:  2020-02-25       Impact factor: 3.786

5.  Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer.

Authors:  Kumardeep Chaudhary; Olivier B Poirion; Liangqun Lu; Lana X Garmire
Journal:  Clin Cancer Res       Date:  2017-10-05       Impact factor: 12.531

6.  Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.

Authors:  Hongda Ding; Junpeng Liu; Ruoyao Zou; Pengrui Cheng; Yang Su
Journal:  J Exp Clin Cancer Res       Date:  2019-05-09

7.  Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.

Authors:  Liman Qiu; Yanbing Huang; Zhenli Li; Xiuqing Dong; Geng Chen; Haipo Xu; Yongyi Zeng; Zhixiong Cai; Xiaolong Liu; Jingfeng Liu
Journal:  Mol Oncol       Date:  2019-01-09       Impact factor: 6.603

8.  LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma.

Authors:  Chuan-Zhuo Wang; Guang-Xin Yan; De-Shuo Dong; He Xin; Zhao-Yu Liu
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

9.  Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Kuang-Tzu Huang; I-Ying Kuo; Ming-Chao Tsai; Chun-Hsien Wu; Li-Wen Hsu; Li-Yu Chen; Chao-Pin Kung; Yu-Fan Cheng; Shigeru Goto; Yu-Wei Chou; Chao-Long Chen; Chih-Che Lin; Kuang-Den Chen
Journal:  Mol Ther Nucleic Acids       Date:  2017-10-07

10.  TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation.

Authors:  Suryakant Niture; Maxwell A Gyamfi; Minghui Lin; Uchechukwu Chimeh; Xialan Dong; Weifan Zheng; John Moore; Deepak Kumar
Journal:  Cell Death Dis       Date:  2020-03-09       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.